Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
That looks l proper blow up which has the mark of a big retrace. Also, should this not be on the HE1 forum?
Hope?
Not entirely sure why you are asking the question. Are you trying to convince yourself whether to buy FUM or not? Sorry if my message sounds brutal, it is not, I am genuinely interested.
As for these types of product it is often difficult to gauge how these might reflect reality. For example, take viagra and studies will claim that it works on average between 45% to 75%. Eroxon is described as working on average at 60%. Viagra is a well known product and I am pretty sure that a lot of people who either have not seen any viagra effect or wanted something else/ more from Eroxon are more likely to be vocal about it. So let's assume that 50% of the reviews are negative, well that's aligned with the studies. It is not a miracle cure by all means.
Also and final point. These products requires a stimuli to work... Is that product failing or is it the man's brain? :)
Trading the 200MA (weekly) @ 37p. So I am more focused on this level than expecting anything more from today's trade. if it holds, my next focus will be how it will trade around that level.
Right now I am feeling that it might be it for a little while... Ain't doing anything, not buying it nor selling. sitting tight.
However if it holds, I am bullish 66p as my next level of importance. Anything lower than that does not rock my boat and will not pay too much attention on the price action between these levels.
Genuinely I am not qualify to advice on anything. I have held most of my position from 2021. I ahve a price target in my mind and will keep to it.
Been holding for years so cannot help you my friend...
Market resumed @ 37p. Let's see how today pans out...
Market suspended on Trading 212...
Liberum: Futura Medical is heading for profit
Futura Medical (FUM) is enjoying a slew of good news and Liberum is confident it can become a profitable company.
Analyst Seb Jantet retained his ‘buy’ recommendation and target price of 142p on the pharmaceutical group, which lowered 2.4%, or 1.6p, to 63.4p yesterday.
Jantet said the positive annual general meeting statement comes ‘hot on the heels of last week’s US approval and includes the news that the initial Eroxon [its erectile dysfunction treatment gel] launch has gone well and guidance that revenues in the first half will be at least £1.5m.’ This is the first time Futura has issued revenue guidance.
This news is on top of a warrant exercise last week, which provided the group with an additional £4m cash injection, that ‘removes any lingering concerns around the balance sheet’.
‘We leave our target price unchanged at 142p but view [the AGM] statement as further evidence that Futura is maturing into a revenue-generating and, ultimately profitable company,’ said Jantet.
My two pence thoughts:
1- It is a shame to issue the RNS on the warrants because it cools off a little bit the market today. For a pure trading perspective it makes the day slightly less interesting as I genuinely wanted the 58/60p resistance to be smashed into pieces. I also felt that the first RNS would have attracted quite a few day traders and other investors who were waiting for the news to come out in order to invest. From that perspective, that has burnt quite a few players, hopefully not too heavily.
2- As a long term investor, I cannot stop thinking that actually this was possibly the best time to issue the warrant RNS. The price inflated sufficiently that the overall impact of this RNS does not hurt my original position (for info I am in at 19p average). This brings liquidity to the company and now that this is out of the way, we can finally see a proper consolidation towards the 60p (which I still want to see destroyed by the way), it also stops the company from needing to extra cash in the short to medium term. So I am fine with it. The dilution is really minor, we talking 3% of the new numbers of shares issued, so the overall impact of the dilution should be minimal right?
I totally get some people can feel hard done by, but for me this is showing that the company is sufficiently aware of the general moving direction and is making the right decisions needed to move this further.
Any thoughts?
PS: I am probably wrong, maybe I should be more worried, so always looking for alternative views.
The 10937500 shares @ 40p is a minimal dilution tbh. So Should not affect the price massively. So I am not seeing a lot of reason to be too concerned. It is a smart way to raise cash and actually I much prefer this has happened after the FDA approval because most of the longer term investors have position at levels much lower than the current sp.
It burns the investors who have bought at the RNS though.
That level will be the first test I will be looking at, if that breaks the next target is 84p.
I am tempted to believe that the 60p resistance will not hold, but what do I know :)
Looking forward how the opening will pan out today. Got in early and been following all the development from this product over the years/months. Time to see if our patience and keeping the position open will be rewarded over the coming weeks. Today's open will be massive.
Come on FUM, time to fly please
Could not ignore these levels for too long.... Bought which did not take too long to fill in, if anyone else is thinking of buying.
would not mind some proper movement.... this 60p barrier has been a pain for quite some time now.... Already on a decent profit and will keep being patient until the take off.
yep I am eyeing 480p to get in
For me this is a good thing. Typically I get quite nervous when I am the last one on the boat. I hope we are in good position for the attention to shift to this company.
dare to expand on this comment? Thanks
I am out now... good luck to everyone riding this share.
not too much of an issue.... I also bought on the drop and I am not too bothered about the prices. Looking if I can add, if not I will just live with the price I have got. :)